Toggle Offcanvas
...
 
Tafluprost Tenders

Tafluprost Tenders

View Tafluprost tenders, RFPs and contracts. Bid on readily available Tafluprost tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Tafluprost tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Tafluprost.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Tafluprost market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Tafluprost tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

9 Live Notices for Tafluprost Tenders

Showing 1 to 9

Completion Of Non-Exclusive Discount Agreements According To Section 130A (8) Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So-Called Open House Process.
country Germany
posting date20 Aug 2025
deadline31 Dec 2026
Completion Of Non-Exclusive Discount Agreements According To Section 130A (8) Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So-Called Open House Process.
country Germany
posting date20 Aug 2025
deadline31 Dec 2026
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Tafluprost + Timolol, Atc S01Ed70 For The Time 01.09.2025 - 31.08.2027
country Germany
posting date17 Jul 2025
deadline05 Jul 2027
Completion Of Non-Exclusive Discount Agreements According To §130A (8) Sgb V On Various Active Ingredient/En/Combinations With Any Final Option Within The Framework Of The So-Called Open House Procedure
country Germany
posting date12 Mar 2025
deadline05 Dec 2025
Pharmaceutical Discount Agreements From April 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date03 Feb 2025
deadline01 Feb 2027
Pharmaceutical Discount Agreements From April 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date03 Feb 2025
deadline01 Feb 2027
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tafluprost (S01Ee05) As Part Of A So-Called Open House Model.
country Germany
posting date17 Apr 2024
deadline31 Mar 2026
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tafluprost (S01Ee05) As Part Of A So-Called Open House Model.
country Germany
posting date16 Apr 2024
deadline31 Mar 2026
SUPPLY OF TAFLUPROST AND TIMOLOL MALEATE EYE DROPS, PRESERVATIVE FREE
country Hong Kong
posting date20 Aug 2025
deadline31 Mar 2027

Share Share this page